Daewoong Pharmaceutical announces ‘3E Global Hyper-Competitive Strategy at CPHI 2023... Aiming for U..
Daewoong Pharmaceutical to Participates in CPHI Worldwide 2023, Showcasing Own Novel Drug in the Glo..
Daewoong Pharmaceutical Initiates Global Export of Novel Drug...Launches Fexuprazan in the Philippin..
.jpg)
Daewoong Pharmaceutical submits a new drug application for Fexuprazan in China… challenging the worl..
Daewoong Pharmaceutical Reports Second Quarter 2023 Financial Results
Daewoong Pharmaceutical’s Fexuprazan takes its first step into Africa… Entering into a partnership w..
.jpg)
Daewoong Pharmaceutical has obtained approval for SGLT2i + metformin combination drug Envlomet
Daewoong Pharmaceutical announces a Global License Agreement for DWP213388, a new drug candidate for..
.jpg)
Daewoong Pharmaceutical Announce Publication of Phase 3 Study of ‘Envlo’, a New Treatment for Diabet..
Daewoong Pharmaceutical and Sygnature Discovery announce drug discovery research collaboration
.jpg)
Daewoong Pharmaceuticals Envlo to enter the global market in full swing... Filing for product licens..
.jpg)